Position in CHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$842,904
-$333,602 QoQ
Shares Held
602,075
-13.5% QoQ
Ownership
0.390%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 145 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 97%
Shared 3%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Derivatives in CHRS
reported options exposure · as of Mar 31, 2020CallValue
$484,978
CallShares
29,900
PutValue
$484,978
PutShares
29,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,040,376,854 across 359 Biotechnology names. CHRS ranks #265 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in CHRS
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $842,904 | 602,075 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $1,176,506 | 696,158 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $436,133 | 307,137 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $627,759 | 382,780 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $242,046 | 331,117 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $441,998 | 547,707 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $737,899 | 534,710 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,160,748 | 2,077,643 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,736,853 | 2,160,031 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,097,831 | 1,714,574 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,789,124 | 837,575 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $4,943,385 | 1,321,761 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $2,239,875 | 524,561 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $4,630,884 | 677,030 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $5,556,607 | 701,592 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $7,421,052 | 772,222 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $4,351,058 | 600,975 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $6,127,846 | 474,659 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,989,246 | 563,236 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $10,485,449 | 652,486 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $7,965,871 | 575,985 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $19,492,705 | 1,334,203 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $24,837,358 | 1,429,077 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $26,876,609 | 1,465,464 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $23,049,079 | 1,290,542 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $24,501,428 | 1,510,569 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $484,978 | 29,900 | Call | Defined | 2020-05-15 | |
| 2020-03-31 | $484,978 | 29,900 | Put | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||